Akili Interactive Labs

By Dave Muoio December 4, 2017
Boston-based Akili Interactive Labs has announced positive results from the largest clinical trial of its video game-based pediatric ADHD treatment yet. In light of these data, the company announced that it now plans to file AKL-T01, also known as Project: Evo ADHD Treatment, for FDA clearance as a novel treatment for children and adolescents with ADHD “This is, any way you slice it, our largest...
By Heather Mack April 5, 2017
There’s plenty of debate about the impact of consumer-level computer or video games on children’s brains. But a new study from the University of California, San Francisco published in PLOS One shows that, in a clinical setting, games that have been developed to function as a medical device may be beneficial to children with certain cognitive impairments. UCSF and Akili Interactive Labs, which is...
By Heather Mack December 12, 2016
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.  The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
By Jonah Comstock November 1, 2016
In 2013, Nature told the world that NeuroRacer, the first health game from the research lab that would spin out to become Akili Labs, was a game changer. While Akili Labs cofounder and Chief Science Advisor Adam Gazzaley might quibble with the details, he definitely thinks mental healthcare is a game in need of a change. “Every researcher wants the pun of ‘game change’ used as a headline in...
By Heather Mack July 29, 2016
During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for the slower news cycle in the summer. In the first half of 2016, MobiHealthNews tracked funding for digital health companies that totaled $1.27 billion, as we...
By Heather Mack July 20, 2016
Digital medicine company Akili Interactive Labs announced an $11.9 million expansion of its recent Series B funding, adding new investors into the round and bringing the series total to $42.4 million. The Dutch subsidiary of Merck Ventures, known as M Ventures in the US and Canada, and the venture arm of Amgen joined existing investors, which include Pfizer and Shire Pharmaceuticals. This means...
By Aditi Pai May 6, 2016
Akili Interactive Labs will soon launch a clinical trial, called STARS-ADHD, that will evaluate the efficacy of its video game intervention for children with ADHD. The company plans to enroll a minimum of 300 children aged 8 to 12 years for its double-blind, randomized, controlled trial. “Project: EVO has shown early promise to help improve attention and neurocognition in cognitive disorders like...
By Aditi Pai January 21, 2016
Boston, Massachusetts-based Akili Interactive Labs, which has developed a video game intervention for cognitive conditions, raised $30.5 million in a round led by PureTech Health with participation from Jazz Venture Partners and Canepa Advanced Healthcare Fund.  This brings the company’s total equity funding to at least $39 million. The company has also received between $5 and $6 million in...
By Aditi Pai October 28, 2015
Project: EVO, an iOS-based video game intervention developed by Akili Interactive Labs, may be an effective method for improving attention and memory in children with ADHD, according to a poster presented at the American Academy of Child and Adolescent Psychiatry’s 62nd annual meeting today. Researchers from Florida Clinical Research Center, SUNY Upstate Medical University, and Duke University...
By Aditi Pai March 3, 2015
Boston-based Akili Interactive Labs has partnered with Delivering Scientific Innovation for Autism (DELSIA), a not-for-profit subsidiary of Autism Speaks. DELSIA is funding an efficacy study of Akili's iOS-based game, called Project: EVO, with children that have high-functioning autism and ADHD. The trial will be a blind, randomized, placebo-controlled study "that will look to measure cognitive...